Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.37 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | RXRA | P19793 | 2/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | F7 | P08709 | 3/20 | 0.34 |
| ▸ | F3 | P13726 | 3/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PPARD | Q03181 | 2/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182648 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1TRPA1OXER1CYP19A1 | |
| SCHEMBL16181330 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1TRPA1OXER1CYP19A1 | |
| Benzene SCHEMBL27667540 | 0.91 | ALDH1A1 (0.43) | ALDH1A1TDP1OXER1CYP19A1PPARG | |
| SCHEMBL9156697 | 0.89 | — | — | |
| SCHEMBL756870 | 0.89 | — | — | |
| SCHEMBL756871 | 0.89 | — | — | |
| SCHEMBL12948684 | 0.89 | — | — | |
| SCHEMBL16178261 | 0.87 | TAS1R3 (0.44) | ALDH1A1OXER1CYP19A1PPARGMAPT | |
| SCHEMBL16178260 | 0.87 | TAS1R3 (0.44) | ALDH1A1OXER1CYP19A1PPARGMAPT | |
| SCHEMBL28541103 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5255516-A | — | — | None | — | — | JP | disclosed |
| US-20100316631-A1 | Water Soluble Curcumin-Based Compounds | THE UAB RESEARCH FOUNDATION (US) | 2010-12-16 | — | — | US | disclosed |
| JP-H05255516-A | PREPARATION OF CROSSLINKED POLYMER | BP CHEM INTERNATL LTD | 1993-10-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316631-A1 | Water Soluble Curcumin-Based Compounds | BAD, TP53, CD14 | ALDH1A1 1330/4885TDP1 4097/4885TRPA1 2068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.